Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type, Technology & Application The global compression therapy market will witness a robust CAGR of 5.2%, valued at $2.98 billion in 2021, expected to appreciate and reach $4.71 billion by 2030, confirms Strategic Market Research. Medical compression treatment uses an elastic device to provide regulated pressure to limbs or other body regions. As a result, the gadget presses the vein walls together, increasing circulation. Compression therapy is most typically used after surgery to minimize swelling and enhance leg circulation. Leg activity, such as walking, normally causes regular contraction and relaxation of the calf muscles to assist in blood circulation from the lower extremities to the heart. Blood clots can form when people are immobile for long periods, such as recovering from surgery. National Blood Clot Alliance reported that 100,000 to 300,000 individuals die from blood clots each year, which is more than the total number of people who die from AIDS, breast cancer, and automobile accidents combined. Medical compression also aids in the reduction of edema and the reproduction of favorable circumstances for the cure of acute inflammation illnesses. Ulnar nerve entrapment treatment massage, fractured spine treatment, treatment for compression fracture, and leg compression therapy are some popular treatments available in the market. The rising number of older adults and sports-related injuries are some of the primary drivers of the global compression market. Drivers - The Rising Number of Older Adults, an Increase in the Abnormality of lifestyle, an Increasing Number of Accidents and Sports-Related Injuries An increasing number of older adults supports the growth of the compression therapy devices market as these people are prone to various health-related issues. According to Age International, average life expectancy has increased by nearly 20 years in the last half-century. As a result, there are currently 962 million individuals over the age of 60, and it’s predicted that by 2050, there will be over 2 billion people aged 60 and more, which is double the amount recorded in 2000. Their bodies demand compression therapy, such as vertebral compression fracture treatments, as they grow older in age. In addition to this, the abnormal lifestyle of today's generation also adds to the growth of this market. This abnormality makes people vulnerable to diseases like obesity, diabetes, high blood pressure, etc. As per the World Health Organization, more than 2.8 million people are losing their lives due to obesity. According to world obesity statistics, countries like England, the United States, and Mexico will have significant obesity rates by 2030, with 35 %, 47 %, and 39 % of the population being overweight or obese. Obesity rates in France are expected to nearly equal those in Spain by 2030, at 21%. Global obesity trends, on the other hand, suggest that the climb would be slower in Korea and Italy, with obesity rates expected to reach 9% and 13%, respectively, by 2030. Hence with the rise of such chronic diseases and increasing awareness, compression therapy is finding its way to a boom in the market. Apart from the above, the growing popularity of sports and speed among the younger generation has created the risk of accidents. The Association for Safe International Road Travel findings reported that road crashes are the biggest reason for fatality in the United States for those aged 1–54. Around 46,000 people are killed in car accidents on American roads every year. The number of road mortalities in the United States is 12.4 deaths per 100,000 people. A further 4.4 million people are gravely hurt and require medical attention. Road crashes cost Americans $871 billion in economic and societal damage. The direct medical costs of road crashes in the United States were more than $380 million, and here, compression therapy is being used in vertebral fracture treatment, pneumatic compression therapy, normatec compression therapy, fractured spine treatment, and game-ready cold therapy to reduce swelling and pain related to post-trauma. Moreover, products like pressure garments, hot and cold gel pack, hot cold packs, game-ready ice for game-ready cold therapy, and Vasopneumatic compression mixed with elevation aids in the recovery of the wounded region. Moreover, the increase in awareness and recent development related to lymphedema and venomous leg is also fueling the growth of the compression therapy market. Restraints - Lack of Awareness & Inefficient Compensation Schemes People in developing countries are still unaware of lymphedema or nasty diseases, which might limit or hamper the growth of this market. Also, an inefficient compensation scheme for compression devices and therapy garments can stand against the market's growth. Opportunities - Growing Obesity and Emerging Economy Growing obesity in the world population creates the risk of more vascular disorders. In one of its surveys, The World Health Organization found that more than 39 Mn children under the age of 5 yrs were obese, and it is predicted that by 2025, 42% of the world population will be overweight. According to MedAlertHelp.org, nearly 1.9 billion individuals globally are considered overweight. According to the World Obesity Federation, nearly half of the world's adult population will be overweight by 2030 if obesity rates continue to rise at their present rate. Furthermore, nearly 200 million school-aged children in the United States are overweight, which will increase the demand for compression therapy, creating an opportunity for the Global market. Emerging economies like India, China, Mexico, Brazil, etc., will add to the growth of the compression therapy devices market size. Factors such as more patient population, a rise in disposable income, better health infrastructure, and an increase in awareness will considerably affect the growth rate of this market. According to Brookings, all developing nations will benefit by $4.4 trillion, or a 7% rise in GDP by 2040. The proportionate increase in GDP in 2040 varies between 7 and 11 %, depending on income level. They also discovered an economic return of $2 to $4 for every $1 invested in health in underdeveloped countries. Market Analysis Of Different Segments Covered in the Report Based on Products Compression Garments Compression Pumps Compression Braces Based on Distribution Channels Clinics and Hospitals E-commerce platforms Retailers and Pharmacies Homecare Based on Techniques Static Therapy Dynamic Therapy Based on Applications Lymphedema Treatments Varicose Vein Treatments Leg Ulcer Treatments Deep Vein Treatments Regional Coverage Analysis North America The U.S. Mexico Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific Japan India Australia China South Korea Rest of Asia-Pacific LAMEA Brazil Saudi Arabia Turkey South Africa Rest of LAMEA Segments Analysis & Insights Based on Products, Compression therapy is divided into three categories: compression garments, braces, and pumps. In 2021, compression garments were predicted to take the lead in the compression therapy industry, and this is mainly due to the widespread usage of compression garments for various causes, including varicose veins, edema, DVT, and lymphedema, and the management of several chronic illnesses. Based on Distribution Channel, owing to the higher adoption of compression therapy and increasing hospitalization rate, the Hospital segment is foreseen to hold the most significant share in the market. Moreover, by 2026, the Homecare segment is expected to grow at the highest CAGR as the number of older adults is continuously increasing, and owing to the current scenario, people are showing more interest in getting their treatment like cold compression therapy done at home with Guyon's canal syndrome treatment. Based on Techniques, because of ease of use and simplicity, Static therapy dominated the compression therapy market in 2020. According to the CDC's athletic injury statistics, 21.9% of all collegiate sports injuries require a seven-day sabbatical before the injured athlete can resume full participation. Approximately 4% of the injuries required surgery (5.4% of injuries acquired on a competitive level and 3.1 % during practice). Furthermore, 0.9% required emergency transportation right away (1.4% at competitions, 0.6 % during practice). Due to its ability to treat sports injuries and edema to relieve pain, the market grew exponentially and acquired the largest share. Based on Applications, the market is divided into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. Because of the increased likelihood of lymphedema and end users' solid preferences for compression therapies for treatment and control, the lymphedema treatment sector is expected to grow at the fastest CAGR during the projected period. The National Library of Medicine disclosed that primary lymphedema affects 1 in 100,000 people. The most frequent cause of lymphedema is secondary lymphedema, which affects about 1 in 1000 Americans. Lymphatic and soft tissue problems can occur over the first 18 months after head and neck cancer therapy, with more than 90% of patients developing internal, external, or mixed lymphedema. More than half of the patients will acquire fibrosis. According to a recent study, within 12 months after treatment for gynecological cancer, 37% of women exhibited detectable signs of lymphedema. Based on Regions, due to the rising awareness among the population and attractive reimbursement policies, the market in the North American region is estimated to lead the Global market in terms of revenue. Rising awareness of venous ulcers, arthritis, sports injuries, and people who have been victims of vehicle accidents are some of the key contributors. In a survey, the National Highway Traffic Safety Administration of the United States Department of Transportation reported an estimated 20,160 individuals died in motor vehicle incidents in the first half of 2021, up 18.4 % from 2020. As traffic accidents in this region increase, compression therapy will be used more frequently during the recovery process, thus driving market growth in this region. North America's compression treatment devices market is worth US$ 1.3 billion and is assumed to prosper at a CAGR of 5.5 % over the next few years. Compression Therapy Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 2.98 Billion The revenue forecast in 2030 USD 4.71 Billion Growth rate CAGR of 5.2 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Distribution Channel, By Technique, By Applications, By Region By Product Compression Garments, Compression Pumps, Compression Braces By Distribution Channel Clinics and Hospitals, E-commerce platforms, Retailers and Pharmacies, Homecare By Technique Static Therapy, Dynamic Therapy By Application Lymphedema Treatments, Varicose Vein Treatments, Leg Ulcer Treatments, Deep Vein Treatments By Region North America, Europe, Asia Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles 3M Company, Medtronic plc, Smith & Nephew plc, Spectrum Healthcare, SIGVARIS, Bio Compression Systems Inc., Sigvaris Management AG, Paul Hartmann AG, BSN Medical GmbH, Gottfried Medical Inc. Global Compression Therapy Market Competitive Landscape Analysis The competitive landscape analysis outlines the most promising competitors operating in the global market. The comparison is based on overall revenue generation, market initiatives, company overview, R&D investment, financials, corporate strengths and weaknesses, global presence, production capacity, locations and facilities, market potential, and other factors. 3M Company, Medtronic plc Smith & Nephew plc, Spectrum Healthcare SIGVARIS, Bio Compression Systems Inc. Sigvaris Management AG Paul Hartmann AG BSN Medical GmbH Gottfried Medical Inc. Colfax Corp. Tactile Systems Technology Inc. Recent Developments On April 2022, Koya Medical, located in Oakland, California, announced the commercial introduction of their Dayspring active compression device in the United States. Koya created the Dayspring compression device to treat lymphedema and venous disorders in the lower limbs. It is a soft, breathable mesh garment with Koya's exclusive Flexframe technology, which uses spring-like parts to generate compression. A smart, rechargeable, Bluetooth-enabled controller is also included, and companion software allows users and physicians to personalize therapies and evaluate treatment histories. On February 2021, a new €1 million innovation partnership was announced to revolutionize compression wound care therapy. Researchers from UCC's Tyndall National Institute and the Royal College of Surgeons will collaborate with DeRoyal Global Healthcare and Henkel, two business partners. The partnership will also include Enterprise Ireland. On November 2020, Therabody, a global leader in tech wellness and the pioneer of percussive massage therapy, announced the acquisition of RP Sports and its revolutionary clinical technology product line, RecoveryPump. Therabody's acquisition of RP Sports marks a watershed moment for the firm, marking a first for the company and expanding its recovery and whole-body wellness solutions by bringing RecoveryPump's therapeutic pneumatic compression technology to the public. Medical and health professionals, professional and college athletes, physiotherapists, and more than 350 sports teams trust RP Sports' RecoveryPump products, FDA-approved Class II medical-grade devices. On July 2020, following several regulatory approvals, AIROS Medical Inc. launched its revised AIROS 6 Sequential Compression Therapy device and Arm Plus garments to treat cancer-related lymphedema and venous problems. The Arm Plus garment, which can be prescribed by a physician to treat lymphedema in the arm, shoulder, chest, and back, has acquired 510(k) clearance from the US Food and Drug Administration (FDA). Various Devices that the Market Leaders are Manufacturing are: Name Feature Key Player Coban 2 Layer Compression System The compression layer is made to be applied at full stretch, which reduces application variability. Patients can use their shoes with the thin, lightweight, breathable sleeve, allowing them to resume regular activities. 3M AIROS 6 The AIROS 6 uses sequential gradient compression to promote extracellular fluid clearance and enhance blood flow. The gadget inflates clothes to transport fluid by cycling compressed air at certain controllable pressures. Spectrum Healthcare Coolflex Standard Calf The Coolflex Standard Calf is an inelastic compression device for the calf that provides 20-50mmHg gradient compression. For skin protection, the gadget is combined with a non-compressive Basic Liner. SIGVARIS Frequently Asked Question About This Report Which is the leading segment among the distribution channel of the market? Owing to the higher adoption of compression therapy and increasing hospitalization rate, the hospital segment is forecasted to hold the most significant chunk of share in the market. What is the compression therapy market growth? The global compression therapy market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2030 to reach USD 4.71 Billion by 2030. What are the most dominant regions of the market? The market in the North American region is estimated to lead the market in terms of revenue. The compression treatment devices market in North America is worth US$ 1.3 billion and is assumed to prosper at a CAGR of 5.5 percent over the next five years. Who are the essential players in the market? The leading key players that are included in the market report are: 3M Company, Medtronic plc, Smith & Nephew plc, Spectrum Healthcare, SIGVARIS, Bio Compression Systems Inc., Sigvaris Management AG, Paul Hartmann AG, BSN Medical GmbH, Gottfried Medical Inc., Colfax Corp., Tactile Systems Technology Inc. How big is this compression therapy market size ? The global compression therapy market size was $2.98 Bn in 2021 and is predicted to reach $4.71 Bn by 2030, representing a CAGR of 5.2%. Which is the most dominant type of product in the market? Based on Product, in 2021, compression garments were predicted to take the lead in the industry. Sources https://ourworldindata.org/life-expectancy https://www.oecd.org/about/secretary-general/heavy-burden-of-obesity-mexico-january-2020.htm https://www.usatoday.com/story/news/nation/2014/05/29/steep-economic-toll-of-crashes/9715893/ https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight https://pubmed.ncbi.nlm.nih.gov/27820152/ https://www.brookings.edu/blog/future-development/2020/07/21/how-investing-in-health-has-a-significant-economic-payoff-for-developing-economies/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Compression Therapy Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Compression Therapy Market 4.2.1 Global Market, 2020 – 2028 (USD Million) 4.3 Regional Analysis 4.3.1 Global Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Analysis 4.4.1 Global Market, By Product, 2021 - 2030 (USD Million) 4.5 By Distribution Channels Analysis 4.5.1 Global Market, By Distribution Channels, 2021 - 2030 (USD Million) 4.6 Application Analysis 4.6.1 Global Market, By Application, 2021 - 2030 (USD Million) 4.6 Techniques Analysis 4.6.1 Global Market, By Techniques, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Techniques Analysis 5.11.1. Trends in Techniques (2014-2020) 5.11.2. Trends in Techniques (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Compression Therapy Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Compression Garments 7.3.1. Compression Garments Market, 2021 - 2030 (USD Million) 7.4. Compression Pumps 7.4.1. Compression Pumps market, 2021 - 2030 (USD Million) 7.5. Compression Braces 7.5.1 Compression Braces market, 2021 - 2030 (USD Million) 8. Global Market: By Distribution Channels Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Clinics and Hospitals 8.3.1. Clinics and Hospitals market, 2021 - 2030 (USD Million) 8.4. E-commerce platforms 8.4.1. E-commerce platforms Market, 2021 - 2030 (USD Million) 8.5. Retailers and Pharmacies 8.5.1. Retailers and Pharmacies Market, 2021 - 2030 (USD Million) 8.6. Homecare 8.6.1. Homecare Market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Lymphedema Treatments 9.3.1. Lymphedema Treatments market, 2021 - 2030 (USD Million) 9.4. Varicose Vein Treatments 9.4.1. Varicose Vein Treatments Market, 2021 - 2030 (USD Million) 9.5. Leg Ulcer Treatments 9.5.1. Leg Ulcer Treatments Market, 2021 - 2030 (USD Million) 9.6. Deep Vein Treatments 9.6.1. Deep Vein Treatments Market, 2021 - 2030 (USD Million) 10. Global Market: By Techniques Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Static Therapy 10.3.1. Static Therapy market, 2021 - 2030 (USD Million) 10.4. Dynamic Therapy 10.4.1. Dynamic Therapy market, 2021 - 2030 (USD Million) 11. Global Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 11.1.2. North AmericaMarket, By Distribution Channels, 2021 - 2030 (USD Million) 11.1.3. North America Market, by Techniques, 2021 - 2030 (USD Million) 11.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 11.1.4.1.2. U.S. Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.1.4.1.3. U.S. Market, by Techniques, 2021 - 2030 (USD Million) 11.1.4.2.Canada 11.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada Market, by Techniques, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 11.2.2. Europe Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.2.3. Europe Market, By Techniques, 2021 - 2030 (USD Million) 11.2.4. Europe Market, By country, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. Market, By Techniques, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany Market, By Techniques, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 11.2.4.3.2. France Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.2.4.3.3. France Market, By Techniques, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, By Techniques, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.3. Asia Pacific Market, By Techniques, 2021 - 2030 (USD Million) 11.3.4. Asia Pacific Market, By country, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 11.3.4.1.2. China Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.4.1.3. China Market, By Techniques, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 11.3.4.2.2. India Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.4.2.3. IndiaMarket, By Techniques, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. JapanMarket, By Product, 2021 - 2030 (USD Million) 11.3.4.3.2. JapanMarket, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan Market, By Techniques, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 11.3.4.4.2. South Korea Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea Market, by Techniques, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFICMarket, By Product, 2021 - 2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFICMarket, By Distribution Channels, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFICMarket, by Techniques, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 11.4.2. Latin America Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.4.3. Latin America Market, by Techniques, 2021 - 2030 (USD Million) 11.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 11.4.4.1.2. Brazil Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil Market, by Techniques, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 11.4.4.2.2. Mexico Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico Market, by Techniques, 2021 - 2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin AmericaMarket, By Product, 2021 - 2030 (USD Million) 11.4.4.3.2. Rest of the Latin AmericaMarket, By Distribution Channels, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin AmericaMarket, by Techniques, 2021 - 2030 (USD Million) 11.5. MEA 11.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 11.5.2. MEA Market, By Distribution Channels, 2021 - 2030 (USD Million) 11.5.3. MEA Market, by Techniques, 2021 - 2030 (USD Million) 11.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 3M Company 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. ProductPortfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Medtronic plc 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Smith & Nephew plc 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Spectrum Healthcare 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. SIGVARIS 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Bio Compression Systems Inc. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Sigvaris Management AG 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Paul Hartmann AG 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. BSN Medical GmbH 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Gottfried Medical Inc. 12.10.1.Company overview 12.10.2.Financial performance 12.10.3.Product Portfolio Analysis 12.10.4.Business Strategy & Recent Development 12.11. Colfax Corp 12.11.1.Company overview 12.11.2.Financial performance 12.11.3.Product Portfolio Analysis 12.11.4.Business Strategy & Recent Development 12.12. Tactile Systems Technology Inc. 12.12.1.Company overview 12.12.2.Financial performance 12.12.3.Product Portfolio Analysis 12.12.4.Business Strategy & Recent Development List of Tables (58 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Compression Garments, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Compression Pumps, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Compression Braces, BY REGION, 2021-2030 (USD Million) TABLE 5. Market, By Distribution Channels, 2021-2030 (USD Million) TABLE 6. Market FOR Clinics and Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR E-commerce platforms, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Retailers and Pharmacies, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Homecare, BY REGION, 2021-2030 (USD Million) TABLE 10. Market, BY TECHNIQUES, 2021-2030 (USD Million) TABLE 11. Market FOR Static Therapy, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Dynamic Therapy, BY REGION, 2021-2030 (USD Million) TABLE 13. Market, BY Application, 2021-2030 (USD Million) TABLE 14. Market FOR Lymphedema Treatments, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Varicose Vein Treatments, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Leg Ulcer Treatments, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Deep Vein Treatments, BY REGION, 2021-2030 (USD Million) TABLE 18. Market, BY REGION, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA Market, By Distribution Channels, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA Market, BY TECHNIQUES, 2021-2030 (USD Million) TABLE 23. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 25. EUROPE Market, By Distribution Channels, 2021-2030 (USD Million) TABLE 26. EUROPE Market, BY TECHNIQUES, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC Market, By Distribution Channels, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC Market, BY TECHNIQUES, 2021-2030 (USD Million) TABLE 31. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 33. LAMEA Market, By Application, 2021-2030 (USD Million) TABLE 34. LAMEA Market, BY TECHNIQUES, 2021-2030 (USD Million) TABLE 35. 3M Company: COMPANY SNAPSHOT TABLE 36. 3M Company: OPERATING SEGMENTS TABLE 37. Medtronic plc: COMPANY SNAPSHOT TABLE 38. Medtronic plc: OPERATING SEGMENTS TABLE 39. Smith & Nephew plc: COMPANY SNAPSHOT TABLE 40. Smith & Nephew plc: OPERATING SEGMENTS TABLE 41. Spectrum Healthcare: COMPANY SNAPSHOT TABLE 42. Spectrum Healthcare: OPERATING SEGMENTS TABLE 43. SIGVARIS: COMPANY SNAPSHOT TABLE 44. SIGVARIS: OPERATING SEGMENTS TABLE 45. Bio Compression Systems Inc.: COMPANY SNAPSHOT TABLE 46. Bio Compression Systems Inc.: OPERATING SEGMENTS TABLE 47. Sigvaris Management AG: COMPANY SNAPSHOT TABLE 48. Sigvaris Management AG: OPERATING SEGMENTS TABLE 49. Paul Hartmann AG: COMPANY SNAPSHOT TABLE 50. Paul Hartmann AG: OPERATING SEGMENTS TABLE 51. BSN Medical GmbH: COMPANY SNAPSHOT TABLE 52. BSN Medical GmbH: OPERATING SEGMENTS TABLE 53. Gottfried Medical Inc.: COMPANY SNAPSHOT TABLE 54. Gottfried Medical Inc.: OPERATING SEGMENTS TABLE 55. Colfax Corp.: COMPANY SNAPSHOT TABLE 56. Colfax Corp.: OPERATING SEGMENTS TABLE 57. Tactile Systems Technology Inc: COMPANY SNAPSHOT TABLE 58. Tactile Systems Technology Inc: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 12 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Compression Therapy, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Compression Therapy, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Distribution Channels, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Techniques, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Compression Garments to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Static Therapy to Witness Higher CAGR in Market for Techniques Segment during Forecast Period. Figure 18 Hospitals to Witness Higher CAGR in Market for Distribution Channels Segment during Forecast Period. Figure 19 Lymphedema Treatments to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview